1. Market Research
  2. > Pathology
39 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 204 pages

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028 Summary Age-related macular degeneration (AMD) is an eye condition that is characterized by the gradual deterioration ...

  • Lymphoma
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • Australasia

2024 World Hematology and Flow Cytometry Analyzers and Reagents Market: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 25000
  • July 2020
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • World

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • January 2019
  • 201 pages

ALTHOUGH CELLTRION' S TRUXIMA WAS SIMILARLY TREATED BY THE FDA, THE COMPANY COMPLIED WITH REQUESTS FOR ADDITIONAL DATA AND IN NOVEMBER 2018, CELLTRION' S TRUXIMA WAS APPROVED, BUT ONLY FOR THE TREATMENT OF B-CELL NON-HODGKIN AND FOLLICULAR LYMPHOMAS (CELLTRION, PRESS RELEASE, ## NOV

  • Biosimilar
  • Hospital
  • Lymphoma
  • Therapy
  • Australasia

Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model

  • $ 7500
  • December 2018
  • 1 pages

Specifically, sources indicate that up to ##-##% of patients infected with HTLV-I develop adult T-cell Leukemia/ Lymphoma (ATLL) or HTLV-I-associated Myelopathy/ Tropical Spastic Paraparesis (HAM/ TSP).

  • Diagnostics
  • Lymphoma
  • Australasia
  • World
  • Supply

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

  • $ 1995
  • November 2019
  • 180 pages

It also discontinued GSK-## in Phase I stage of development for follicular lymphoma, diffuse large Bcell lymphoma, solid tumor, and refractory multiple myeloma.

  • Lymphoma
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Australasia

World Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation

  • $ 35000
  • September 2019
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • World

World Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the Americas, EMEA, APAC--A 74-Country Analysis

  • $ 37500
  • June 2019
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • World

2024 Australia Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 1450
  • July 2020
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • Australia

2024 New Zealand Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 1450
  • July 2020
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • New Zealand

2024 Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market: A 17-Country Analysis

  • $ 9500
  • July 2020
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

Australia Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • September 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • Australia

New Zealand Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • September 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • New Zealand

Australia Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • June 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • Australia

New Zealand Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • June 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • New Zealand

Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 9500
  • September 2019
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 14700
  • June 2019
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • February 2017
  • 403 pages

HOWEVER, PATIENTS WITH RA ARE KNOWN TO BE AT A HIGHER RISK FOR DEVELOPING LYMPHOMA.

  • Biosimilar
  • Epidemiology
  • Hospital
  • Lymphoma
  • Australasia

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 211 pages

The targeted subindications are mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

  • Leukemia
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Australasia

Australia General Surgery Market Outlook to 2023 - Aesthetic Lasers and Energy Devices, Bariatric Surgery Devices, Biopsy Devices, Bronchoscopes, Colonoscopes, Cystoscopes, Duodenoscopes, Endoscopy Fluid Management Systems and Others

  • $ 5995
  • May 2017
  • 564 pages

LYMPHOMA CONSUMERS AND HEALTH PROFESSIONALS ARE ADVISED THAT THE TGA HAS CONTINUED TO MONITOR THE ASSOCIATION BETWEEN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) AND BREAST IMPLANTS SINCE WE PUBLISHED A SAFETY COMMUNICATION REGARDING THIS ISSUE ON ## JANUARY 2011.

  • Biopsy
  • Endoscope
  • Lymphoma
  • Australasia
  • Australia

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • September 2017
  • 433 pages

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2026 Summary Melanoma is the deadliest and most aggressive form of skin cancer. Melanoma is rare compared to other major cancer indications, ...

  • Hospital
  • Lymphoma
  • Therapy
  • Australasia
  • Merck & Co., Inc.
View report >

Cancer Statistics

  • February 2020
  • 66 pages

Salivary gland Polycythaemia vera Oropharynx Other lymphomas Thymus Eye Nose, nasal cavities, middle ear and accessory sinuses Larynx Other endocrine glands Skin of anus (including perineum, perianal skin) Nasopharynx Malignancy of histiocytes and accessory lymphoid cells Unspecified sites

  • Cancer
  • Lymphoma
  • Pathology
  • Australasia
  • Demographic

Cancer Statistics June 2019

Cancer Statistics January 2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on